
ADVANCED DRUG DELIVERY REVIEWS
ISSN | 0169-409X | 影响因子 | 17.6 | 自引率 | 2.80% | 研究类文章占比 | 0.00% | 中科院分区 | 医学 1区 |
h-index | 278 | 年文章数 | 111 | OA文章占比 | 20.87% | JCI期刊引文指标 | 2.31 | JCR分区 | Q1 |
期刊简称
ADV DRUG DELIVER REV
期刊简介
The aim of the Journal is to provide a forum for the critical analysis of advanced drug and gene delivery systems and their applications in human and veterinary medicine. The Journal has a broad scope, covering the key issues for effective drug and gene delivery, from administration to site-specific delivery.In general, the Journal publishes review articles in a Theme Issue format. Each Theme Issue provides a comprehensive and critical examination of current and emerging research on the design and development of advanced drug and gene delivery systems and their application to experimental and clinical therapeutics. The goal is to illustrate the pivotal role of a multidisciplinary approach to modern drug delivery, encompassing the application of sound biological and physicochemical principles to the engineering of drug delivery systems to meet the therapeutic need at hand. Importantly the Editorial Team of ADDR asks that the authors effectively window the extensive volume of literature, pick the important contributions and explain their importance, produce a forward looking identification of the challenges facing the field and produce a Conclusions section with expert recommendations to address the issues.Articles review the current status of a specific topic, giving equal emphasis to the identification of major conceptual and technological challenges to successful drug and gene delivery, to an evaluation of triumphs as well as shortcomings in current conceptual and technical approaches, and to a discussion of their possible solution.
期刊官网
https://www.journals.elsevier.com/advanced-drug-delivery-reviews
投稿网址
https://www.editorialmanager.com/ADDR
通讯方式
ELSEVIER SCIENCE BV, PO BOX 211, AMSTERDAM, NETHERLANDS, 1000 AE
出版商
Elsevier
出版周期
Monthly
语言
English
创刊时间
1987
所属国家/地区
NETHERLANDS
涉及的研究方向
医学-药学
是否OA
No
PubMed Central链接
http://www.ncbi.nlm.nih.gov/nlmcatalog?term=0169-409X%5BISSN%5D
SCI期刊收录coverage
中国科学院《国际期刊预警名单(试行)》名单
2025年03月发布的2025版:不在预警名单中
2024年02月发布的2024版:不在预警名单中
2023年01月发布的2023版:不在预警名单中
2021年12月发布的2021版:不在预警名单中
2020年12月发布的2020版:不在预警名单中
2025年中国科学院期刊分区
大类学科 | 小类学科 | Top期刊 | 综述期刊 |
---|---|---|---|
医学1区 | PHARMACOLOGY & PHARMACY药学1区 | 是 | 是 |
Cite Score
Cite Score | SJR | SNIP | 排名 | ||||||
---|---|---|---|---|---|---|---|---|---|
36.00 | 3.721 | 2.485 |
|
历年JCR分区
[["2018-2019年度", "2019-2020年度", "2020-2021年度", "2021-2022年度", "2022-2023年度", "2023-2024年度"], [1, 1, 1, 1, 1, 1]]
历年影响因子
[["2015-2016年度","2016-2017年度","2017-2018年度","2018-2019年度","2019-2020年度","2020-2021年度","2021-2022年度","2022-2023年度","2023-2024年度","2024-2025年度"],[15.606,11.764,13.66,15.519,13.3,15.47,17.873,16.1,15.2,17.6]]
历年自引率
[["2015-2016年度","2016-2017年度","2017-2018年度","2018-2019年度","2019-2020年度","2020-2021年度","2021-2022年度","2022-2023年度","2023-2024年度","2024-2025年度"],[1.3,2.1,1.3,2.1,2.5,2,4.7,5,3.9,2.8]]
历年文章数量
[["2014-2015年度","2015-2016年度","2016-2017年度","2017-2018年度","2018-2019年度","2019-2020年度","2020-2021年度","2021-2022年度","2022-2023年度","2023-2024年度","2024-2025年度"],[116,156,182,142,155,145,130,312,254,174,111]]